Blog

The financial sector has been hit hard since the beginning of March. The collapse of SVB Financial's Silicon Valley Bank, Signature Bank, and most recently First Republic has left investors uneasy

Artificial intelligence (AI) has taken center stage in 2023. The emergence of next-level generative AI systems -- including OpenAI's ChatGPT -- have given many people the first glimpse of what an

Some companies never compete against each other in the marketplace. However, they do compete, in a sense, for investors. 

International Business Machines (NYSE: IBM) and Medical Properties Trust

Warren Buffett's mentor, Ben Graham, wrote The Intelligent Investor, one of the most revered investment books of all time. The title of that book is an apt description of Buffett himself.

Today

The higher the dividend yield, the higher the level of risk. That assumption has been the conventional wisdom of investors for a long time. It's usually correct -- but not always.

In some cases

Ask investors across all experience levels, and I'm sure many of them will tell you they'd take a redo on their first investments if they had a chance. It happens to the best of us, myself included.

If one of your financial goals is to generate some passive income from dividend stocks, it behooves you to know when the companies in your portfolio are healthy, and when they're in deep danger

Moderna (NASDAQ: MRNA) made a name for itself through its coronavirus vaccine. It's the biotech's first and only product -- and harnesses the company's core messenger RNA technology. The vaccine has

I was talking to a friend of mine recently who's in her mid-40s, and she told me that she's yet to save so much as a dime in an IRA or 401(k) plan, despite working full time for most of her adult

Investing on Wall Street has been nothing short of an adventure for the past 16 months. After hitting their respective all-time highs between November 2021 and the first week of January 2022, all

In case you haven't heard the news, Social Security's not looking so good. The latest Trustees Report has the most dismal outlook to date. The trust funds that keep the program going are estimated

For the vast majority of Social Security beneficiaries, their monthly check is vital to their financial well-being. After 20 years of annual polling, Gallup has found that no less than 80% of

Sturdy real estate company Cushman & Wakefield (NYSE: CWK) wasn't a very sturdy investment on Friday. The company's stock took a nasty hit, falling by nearly 11% a day after it published its latest

Investors breathed a large, collective sigh of relief at the latest news from electric vehicle (EV) manufacturer Fisker (NYSE: FSR) on Friday. The company finally delivered its first Ocean SUV, and

Shares of Roku (NASDAQ: ROKU) were pulling back last month as investors responded to a mixed bag of news items, including a middling earnings report from the leading streaming distribution platform.

In this Motley Fool Money podcast, host Chris Hill and Motley Fool senior analyst Bill Mann discuss:

Also, Motley Fool Answers co-host Alison Southwick and Motley Fool personal finance expert Robert

TAL Education Group (NYSE: TAL) wasn't in a good position to instruct companies on how to boost their stock price this week.

The Chinese for-profit learning company's American Depositary Shares

Zebra Technologies (NASDAQ: ZBRA) was hardly the most impressive animal on the stock exchange this week. According to data compiled by S&P Global Market Intelligence, the company's share price slid

Shares of Carvana (NYSE: CVNA) pulled back again in April after the volatile online used car dealer continued to negotiate with its bondholders, and the economy showed signs of risk from the banking

It has been a little over a year since Discovery merged with WarnerMedia to create Warner Bros. Discovery (NASDAQ: WBD). And while the entertainment company spent much of its first 12 months

This week was not kind to education stocks. Exhibit A: the performance of sector mainstay Coursera (NYSE: COUR). The company's share price sank by almost 12% over the course of the five trading

Shares of Summit Therapeutics (NASDAQ: SMMT) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which

Broadly speaking, the overall cryptocurrency market has performed relatively well over the past week. Interest in various megacap tokens has propelled the sector higher, though certain lesser known

Image source: The Motley Fool.

Xponential Fitness (NYSE: XPOF)Q1 2023 Earnings CallMay 04, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

Proto Labs (NYSE: PRLB)Q1 2023 Earnings CallMay 05, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com